サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375206

欧州のバイオプロセス技術市場の2028年までの予測-タイプ、モダリティ、エンドユーザー別の地域別分析

Europe Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 143 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
欧州のバイオプロセス技術市場の2028年までの予測-タイプ、モダリティ、エンドユーザー別の地域別分析
出版日: 2023年09月14日
発行: The Insight Partners
ページ情報: 英文 143 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のバイオプロセス技術市場は、2023年の122億9,088万米ドルから2028年には265億8,836万米ドルに成長すると予測されています。2023年から2028年までのCAGRは16.7%と推定されます。

先進バイオプロセス技術の導入が欧州のバイオプロセス技術市場を牽引

先進バイオプロセス技術は、研究開発と生産の橋渡しをします。複数の企業が幅広いバイオプロセス新技術を市場に導入しています。2020年12月4日、IDBS（バイオテクノロジーおよび製薬業界向けソフトウェア・インフォマティクス・ソリューションのプロバイダー）はPolarの発売を発表しました。Polarは、バイオファーマ研究における医薬品開発と生産を合理化するために、バイオファーマライフサイクルマネジメント（BPLM）と呼ばれる新しい製品カテゴリーを創設します。Polarは、実験室情報管理システム（LIMS）や電子実験ノート（ELN）など、既存のソフトウェア・ソリューションを悩ませてきたワークフロー、プロセス品質、コラボレーション、データ分析に関連する課題を迅速に解決するために設計され、展開されます。その結果、人的ミスが減り、全体的な精度が向上します。手作業によるデータ処理と転記を減らし、ヒューマンエラーの減少と全体的な精度の向上につながります。また、検索機能が充実しているため、ユーザーが探しているものを簡単に見つけることができ、無意味な労力の重複を防ぐことができます。

メトラー・トレドのDynochem Biologicsは、あらゆる規模のバイオプロセスにおけるアップストリームおよびダウンストリームユニット活動をサポートする専用シミュレーションソフトウェアです。バイオプロセスのエンジニアや科学者は、このソフトウェアを使用して、適切なプロセス操作パラメータを選択し、スケールの同等性を確立します。公益事業は、最小限のデータで装置性能を迅速に評価できる一方、より強力なモデルは、既存のデータストリームをプロセスの特性評価に活用します。対応可能なアプリケーションの専門知識、豊富なトレーニング・リソース、すでに構築されているモデル・ライブラリーを活用することで、初期プロジェクトを迅速に完了することができます。ペプチド、mAbs、ワクチン接種、ウイルスベクターは、多くのアプリケーションのほんの一例です。

メルクの新しいBioContinuumプラットフォームは、効率性の向上、工場運営の簡素化、品質と一貫性の向上を通じて、バイオ治療薬の製造を進歩させます。さらに、メルクのPellicon Single-Pass Tangential Flow Filtrationは、治療用タンパク質の精製に関連する業務の強化を支援します。このように、様々な新時代のバイオプロセス技術のイントロダクションは、予測期間中の市場成長に有利な機会を提供すると思われます。

欧州のバイオプロセス技術市場概要

ドイツ貿易投資庁によると、欧州は世界第2位の医薬品輸出国であり、世界の医薬品生産国の上位にランクされています。個別化医療に対する需要の高まりを受けて、ドイツは新規バイオ医薬品の主要供給国のひとつにもなっています。生物製剤は高い治療効果が期待できるため、ドイツの医薬品市場でかなりのシェアを占めています。ドイツ貿易投資総省（GTAI）の報告書によると、2015年から2019年にかけて、生物製剤市場は年平均11.6％成長した（医薬品市場全体の成長率の2倍以上）。ドイツにおけるバイオ医薬品の総売上高は2019年に139億6,000万米ドルとなり、医薬品市場の4分の1以上に相当します。ドイツは欧州の主要医薬品市場を擁し、世界第4位です。2019年、ドイツの製薬業界の売上高は2018年から5.7％増加し、510億1,000万米ドル（メーカー出荷価格）に達しました。ドイツには500社以上の製薬会社があります。中小企業は経済セクターの屋台骨であり、医薬品メーカーの約90％は従業員数500人未満です。バイオテクノロジーが製薬会社の新製品、新工程、新製法、新サービスの開発や既存製品の改良に役立っているため、欧州の医薬品市場の開拓はバイオプロセス技術の利用を促進すると思われます。

欧州のバイオプロセス技術市場の収益と2028年までの予測（金額）

欧州のバイオプロセス技術市場のセグメンテーション

欧州のバイオプロセス技術市場は、タイプ、モダリティ、エンドユーザー、国に区分されます。

タイプ別では、欧州のバイオプロセス技術市場は、細胞培養培地バイオプロセス、クロマトグラフィーバイオプロセス、消耗品＆アクセサリー、その他に区分されます。2023年には、消耗品＆アクセサリー分野が欧州のバイオプロセス技術市場で最大のシェアを記録しました。

モダリティに基づき、欧州のバイオプロセス技術市場は単一使用と複数使用に二分されます。2023年、欧州のバイオプロセス技術市場では、単一使用分野がより大きなシェアを記録しました。

エンドユーザーに基づくと、欧州のバイオプロセス技術市場は学術・医療機関、バイオ製薬会社、研究所、その他に区分されます。2023年には、バイオ製薬会社セグメントが欧州のバイオプロセス技術市場で最大のシェアを記録しました。

国別では、欧州のバイオプロセス技術市場は、英国、ドイツ、フランス、イタリア、スペイン、その他の欧州に区分されます。2023年には、ドイツセグメントが欧州のバイオプロセス技術市場で最大のシェアを記録しました。

BioPharma Dynamics Ltd、Corning Inc、Danaher Corp、Eppendorf SE、Lonza Group AG、Merck KGaA、Repligen Corp、Sartorius AG、STAMM Biotech、およびThermo Fisher Scientific Incは、欧州のバイオプロセス技術市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 欧州のバイオプロセス技術市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のバイオプロセス技術市場- 市場情勢

  • 概観
  • 欧州PEST分析
  • 専門家の見解

第5章 欧州のバイオプロセス技術市場：主要市場力学

  • 市場促進要因
    • 新薬導入のための研究開発費の増加
    • 慢性疾患の増加
  • 市場抑制要因
    • 厳しい規制政策
  • 市場機会
    • 先進バイオプロセス技術の導入
  • 今後の動向
    • 自動リアルタイムフローサイトメトリー（ARTFCM）の登場
  • 影響分析

第6章 バイオプロセス技術市場：欧州分析

  • 欧州のバイオプロセス技術市場の収益と予測分析

第7章 欧州のバイオプロセス技術市場の分析と2028年までの予測：タイプ別

  • イントロダクション
  • 欧州のバイオプロセス技術市場：タイプ別、2022年・2028年（%）
  • 細胞培養培地バイオプロセス
  • クロマトグラフィーバイオプロセス
  • 消耗品・アクセサリー
  • その他

第8章 欧州のバイオプロセス技術市場の分析と2028年までの予測：モダリティ別

  • イントロダクション
  • 欧州のバイオプロセス技術市場：モダリティ別、2022年・2028年（%）
  • シングルユース
  • 複数用途

第9章 欧州のバイオプロセス技術市場：2028年までの収益と予測：エンドユーザー別

  • イントロダクション
  • 欧州のバイオプロセス技術市場：エンドユーザー別、2022年・2028年（%）
  • 学術・医療機関
  • バイオ医薬品企業
  • 研究機関
  • その他

第10章 欧州のバイオプロセス技術市場：2028年までの収益と予測：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州

第11章 欧州のバイオプロセス技術市場：業界情勢

  • イントロダクション
  • 有機的成長戦略
  • 概要
  • 無機的成長戦略
  • 概要

第12章 企業プロファイル

  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp
  • BioPharma Dynamics Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Europe Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
  • Table 2. Germany Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Germany Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. UK Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. UK Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. UK Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. France Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. France Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. France Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Italy Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Italy Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Italy Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Spain Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Spain Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Spain Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Rest of Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
  • Table 21. Recent Inorganic Growth Strategies in the Europe bioprocess technology market
  • Table 22. Glossary of Terms

List Of Figures

  • Figure 1. Europe Bioprocess Technology Market Segmentation
  • Figure 2. Europe Bioprocess Technology Market, by Country
  • Figure 3. Europe Bioprocess Technology Market Overview
  • Figure 4. Others Segment Held Largest Share of Type Segment in Europe Bioprocess Technology Market
  • Figure 5. UK Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Europe Bioprocess Technology Market Impact and Analysis
  • Figure 9. Europe Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • Figure 11. Cell Culture Media Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Chromatographic Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Consumables & Accessories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Europe Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • Figure 16. Single Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Multiple Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Europe Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 19. Academic & Medical Institutions: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Biopharmaceutical Companies: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Research Laboratories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Europe: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
  • Figure 25. Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028879

The Europe bioprocess technology market is expected to grow from US$ 12,290.88 million in 2023 to US$ 26,588.36 million by 2028. It is estimated to grow at a CAGR of 16.7% from 2023 to 2028.

Introducing Advanced Bioprocess Technologies Drives Europe Bioprocess Technology Market

Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort.

METTLER TOLEDO's Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications.

Merck's new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck's Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.

Europe Bioprocess Technology Market Overview

According to Germany Trade & Invest, the country is the second largest exporter of medicinal products and ranks among the top pharmaceutical producers across the world. Owing to the rising demand for personalized medicine, Germany has also evolved into one of the main suppliers of novel biopharmaceuticals. Biologics hold a considerable share of the pharmaceutical market in Germany due to their high therapeutic potential. According to a report by Germany Trade & Invest (GTAI) from 2015 to 2019, the biologics market grew by 11.6 % on average annually (more than twice the growth of the overall pharma market). The total revenue of biopharmaceuticals in Germany was US$ 13.96 billion in 2019, equivalent to more than a quarter of the pharmaceutical market. Germany has a major European pharmaceutical market and is the fourth largest across the world. In 2019, sales in the pharmaceutical industry in Germany increased by 5.7 %, from 2018, reaching US$ 51.01 billion (ex-manufacturer prices). More than 500 pharmaceutical companies are located in Germany. SMEs are the backbone of the economic sector, with around 90% of drug manufacturers having less than 500 employees. Thus, the growing pharmaceutical market in Europe will propel the use of bioprocess technology as biotechnology helps the pharmaceutical companies develop new products, processes, methods, and services and improve existing ones.

Europe Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Europe Bioprocess Technology Market Segmentation

The Europe bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the Europe bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Europe bioprocess technology market.

Based on modality, the Europe bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Europe bioprocess technology market.

Based on end user, the Europe bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Europe bioprocess technology market.

Based on country, the Europe bioprocess technology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered a largest share in the Europe bioprocess technology market.

BioPharma Dynamics Ltd; Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc are the leading companies operating in the Europe bioprocess technology market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocess technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Bioprocess Technology Market - by Type
    • 1.3.2 Europe Bioprocess Technology Market - by Modality
    • 1.3.3 Europe Bioprocess Technology Market - by End User
    • 1.3.4 Europe Bioprocess Technology Market - by Country

2. Europe Bioprocess Technology Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Bioprocess Technology Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Expert's Opinion

5. Europe Bioprocess Technology Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
    • 5.1.2 Increasing Prevalence of Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies
  • 5.3 Market Opportunities
    • 5.3.1 Introducing Advanced Bioprocess Technologies
  • 5.4 Future Trends
    • 5.4.1 Emergence of Automated Real?Time Flow Cytometry (ART?FCM)
  • 5.5 Impact Analysis

6. Bioprocess Technology Market - Europe Analysis

  • 6.1 Europe Bioprocess Technology Market Revenue Forecast and Analysis

7. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 Europe Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • 7.3 Cell Culture Media Bioprocess
    • 7.3.1 Overview
    • 7.3.2 Cell Culture Media Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Chromatography Bioprocess
    • 7.4.1 Overview
    • 7.4.2 Chromatography Bioprocess: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Consumables & Accessories
    • 7.5.1 Overview
    • 7.5.2 Consumables & Accessories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

  • 8.1 Overview
  • 8.2 Europe Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • 8.3 Single Use
    • 8.3.1 Overview
    • 8.3.2 Single Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Multiple Use
    • 8.4.1 Overview
    • 8.4.2 Multiple Use: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Europe Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • 9.3 Academic & Medical Institutions
    • 9.3.1 Overview
    • 9.3.2 Academic & Medical Institutions: Europe Bioprocess Technology Market - Revenue and Forecast to 2028(US$ Million)
  • 9.4 Biopharmaceutical Companies
    • 9.4.1 Overview
    • 9.4.2 Biopharmaceutical Companies: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 Germany: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.1.4 Germany: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.1.5 Germany: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 UK: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.2.4 UK: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.2.5 UK: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.3 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 France: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.3.4 France: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.3.5 France: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.4 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Italy: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.4.5 Italy: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.5 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Spain: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Spain: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Europe Bioprocess Technology Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sartorius AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Thermo Fisher Scientific Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Corning Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lonza Group AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Repligen Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Danaher Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 BioPharma Dynamics Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms